Cytomx Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.81

+0.05 (+1.81%)

As of Sep 21, 2:26 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +2,143.4% upside

Low Target $39.26

Average Target $63.04

High Target $88.15

Current Price $2.81

Current
$2.81

Target
$63.04

$39.26 $63.04 avg $88.15

Scenario Analysis

Bear Case

$39.26

1,297.2%

Low target

Base Case

$63.04

+2,143.4%

Avg target

Bull Case

$88.15

+3,037.0%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$8.21

-65.8% from high

52-Week Low

$1.93

+45.6% from low

Target vs 52W High

$63.04

+667.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.2%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%